Hidroxicloroquina Aristo (Hydroxychloroquine Sulfate)

Hidroxicloroquina Aristo is indicated for several clinical situations where modulation of the immune system or antimalarial activity is required.

• Prevention of malaria in travelers to endemic regions.
• Treatment of acute malaria infections caused by susceptible Plasmodium species.
• Management of rheumatoid arthritis as part of disease‑modifying therapy.
• Treatment of systemic lupus erythematosus to reduce disease activity.
• Adjunct therapy for certain dermatologic disorders with an autoimmune component.

• Hydroxychloroquine sulfate exerts its pharmacologic effect by accumulating in lysosomes and raising intralysosomal pH, which impairs lysosomal enzyme activity and autophagy. This alteration interferes with antigen processing and presentation, thereby modulating the immune response. Additionally, the drug can inhibit Toll‑like receptor signaling pathways, contributing to its antimalarial and immunomodulatory actions.

Adverse reactions to Hidroxicloroquina Aristo vary in frequency and severity.

Common

• Nausea or upset stomach.
• Diarrhea or abdominal cramps.
• Skin rash or itching.
• Headache.
• Visual disturbances such as blurred vision.

Serious

• Retinal toxicity leading to vision loss.
• Severe skin reactions (e.g., Stevens‑Johnson syndrome).
• Cardiac arrhythmias or cardiomyopathy.
• Hemolytic anemia in patients with G6PD deficiency.
• Hypoglycemia, especially in diabetic patients.

Before initiating Hidroxicloroquina Aristo, several safety considerations should be reviewed.

• Baseline ophthalmologic examination is recommended due to risk of retinal toxicity.
• Assess renal and hepatic function, as impairment may affect drug clearance.
• Screen for glucose‑6‑phosphate dehydrogenase (G6PD) deficiency to avoid hemolysis.
• Monitor cardiac status in patients with pre‑existing heart disease.
• Use caution in pregnancy and breastfeeding; discuss risks with a healthcare provider.
• Inform patients about the need for regular blood count monitoring during long‑term therapy.

Hidroxicloroquina Aristo can interact with several medications, influencing efficacy or safety.

Avoid

• Concurrent use with other QT‑prolonging agents (e.g., certain antiarrhythmics, antipsychotics) due to increased arrhythmia risk.
• Combination with strong CYP2D6 inhibitors, which may raise hydroxychloroquine levels.
• Co‑administration with drugs that cause hypoglycemia, such as insulin or sulfonylureas.

Use with caution

• Antacids or supplements containing calcium, magnesium, or aluminum, which may reduce absorption.
• Immunosuppressants, as additive immunomodulatory effects may increase infection risk.
• Live vaccines, because immune response may be attenuated.
• NSAIDs, which may increase the risk of gastrointestinal irritation.